Vogt MH - Search Results

1

Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.

Vogt MH, Lopatinskaya L, Smits M, Polman CH, Nagelkerken L. Vogt MH, et al. Ann Neurol. 2003 Jun;53(6):819-22. doi: 10.1002/ana.10606. Ann Neurol. 2003. PMID: 12783433

2

Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients.

Vogt MH, Floris S, Killestein J, Knol DL, Smits M, Barkhof F, Polman CH, Nagelkerken L. Vogt MH, et al. J Neuroimmunol. 2004 Oct;155(1-2):155-60. doi: 10.1016/j.jneuroim.2004.06.007. J Neuroimmunol. 2004. PMID: 15342207

3

Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers.

Vogt MH, ten Kate J, Drent RJ, Polman CH, Hupperts R. Vogt MH, et al. Mult Scler. 2010 Apr;16(4):443-9. doi: 10.1177/1352458509359723. Epub 2010 Jan 19. Mult Scler. 2010. PMID: 20086024

4

Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.

Tewarie P, Teunissen CE, Dijkstra CD, Heijnen DA, Vogt M, Balk L, Vrenken H, Polman CH, Killestein J. Tewarie P, et al. J Neuroimmunol. 2012 Oct 15;251(1-2):103-6. doi: 10.1016/j.jneuroim.2012.07.002. Epub 2012 Aug 2. J Neuroimmunol. 2012. PMID: 22858371

5

Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.

Vogt MH, Teunissen CE, Iacobaeus E, Heijnen DA, Breij EC, Olsson T, Brundin L, Killestein J, Dijkstra CD. Vogt MH, et al. J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1110-5. doi: 10.1136/jnnp.2008.146357. Epub 2008 Oct 17. J Neurol Neurosurg Psychiatry. 2009. PMID: 18931010

6

Analysis of the effect of temperature and reaction time on yields, compositions and oil quality in catalytic and non-catalytic lignin solvolysis in a formic acid/water media using experimental design.

Oregui Bengoechea M, Miletíc N, Vogt MH, Arias PL, Barth T. Oregui Bengoechea M, et al. Among authors: vogt mh. Bioresour Technol. 2017 Jun;234:86-98. doi: 10.1016/j.biortech.2017.02.129. Epub 2017 Mar 1. Bioresour Technol. 2017. PMID: 28319777

7

A multicenter evaluation of dysthyroxinemia in a defined patient cohort.

Vogt MH, Bons JA, Janssen MJ, Naus A, Oosterhuis W, Ten Kate J, Menheere PP. Vogt MH, et al. Clin Chem Lab Med. 2014 Aug;52(8):1153-8. doi: 10.1515/cclm-2014-0063. Clin Chem Lab Med. 2014. PMID: 24717338

8

Detection of differential protein expression in cerebrospinal fluid of patients with multiple sclerosis through two-dimensional differential in gel electrophoresis.

Pulinx B, Hupperts RM, Vogt MH, ten Kate J, van Dieijen-Visser MP, Wodzig WK. Pulinx B, et al. Among authors: vogt mh. Clin Chem Lab Med. 2012;50(9):1693-5. doi: 10.1515/cclm-2012-0011. Clin Chem Lab Med. 2012. PMID: 23089612 No abstract available.

9

The microtubule regulator stathmin is an endogenous protein agonist for TLR3.

Bsibsi M, Bajramovic JJ, Vogt MH, van Duijvenvoorden E, Baghat A, Persoon-Deen C, Tielen F, Verbeek R, Huitinga I, Ryffel B, Kros A, Gerritsen WH, Amor S, van Noort JM. Bsibsi M, et al. Among authors: vogt mh. J Immunol. 2010 Jun 15;184(12):6929-37. doi: 10.4049/jimmunol.0902419. Epub 2010 May 12. J Immunol. 2010. PMID: 20483774

10

Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins.

Bsibsi M, Bajramovic JJ, Van Duijvenvoorden E, Persoon C, Ravid R, Van Noort JM, Vogt MH. Bsibsi M, et al. Among authors: vogt mh. Glia. 2007 Apr 1;55(5):473-82. doi: 10.1002/glia.20473. Glia. 2007. PMID: 17205552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters